Clearbridge Health (SGX:1H3) launched its adult immune cell banking business, according to a Monday filing with the Singapore Exchange.
The service allows clients to collect and store their peripheral blood mononuclear cells, which are essential for autologous immunotherapy treatments.
The business will be operated through its subsidiary, Cell Entrust Bio, which is based in Hong Kong.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.